إعلان
إعلان

TWST

TWST logo

Twist Bioscience Corporation Common Stock

35.34
USD
برعاية
+0.60
+1.73%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

35.50

+0.16
+0.45%

تقارير أرباح TWST

النسبة الإيجابية المفاجئة

TWST تفوق 18 من 29 آخر التقديرات.

62%

التقرير التالي

بيانات التقرير القادم
٣٠ يناير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
$102.37M
/
-$0.44
التغير الضمني من Q4 25 (Revenue/ EPS)
+3.39%
/
-2.22%
التغير الضمني من Q1 25 (Revenue/ EPS)
+15.39%
/
-16.98%

Twist Bioscience Corporation Common Stock earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, TWST reported earnings of -0.45 USD per share (EPS) for Q4 25, missing the estimate of -0.43 USD, resulting in a -2.79% surprise. Revenue reached 99.01 مليون, compared to an expected 99.26 مليون, with a -0.26% difference. The market reacted with a -10.13% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 المحللين forecast an EPS of -0.44 USD, with revenue projected to reach 102.37 مليون USD, implying an نقصان of -2.22% EPS, and زيادة of 3.39% in Revenue from the last quarter.
الأسئلة الشائعة
For Q4 2025, Twist Bioscience Corporation Common Stock reported EPS of -$0.45, missing estimates by -2.79%, and revenue of $99.01M, -0.26% below expectations.
The stock price moved down -10.13%, changed from $29.90 before the earnings release to $26.87 the day after.
The next earning report is scheduled for ٣٠ يناير ٢٠٢٦.
Based on 11 المحللين, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.44 and revenue of $102.37M for Q1 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان